The Chicago Entrepreneur

Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.

Even if they’re not acquired, these small companies are developing promising obesity and diabetes treatments.

Previous post Inflation in New Zealand eases, but rate cuts unlikely in near term
Next post UK inflation eases less than expected to 3.2% in March